These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17669098)

  • 1. A report card to grade Helicobacter pylori therapy.
    Graham DY; Lu H; Yamaoka Y
    Helicobacter; 2007 Aug; 12(4):275-8. PubMed ID: 17669098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
    Graham DY; Lu H; Yamaoka Y
    Drugs; 2008; 68(6):725-36. PubMed ID: 18416582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Helicobacter pylori.
    Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
    Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Helicobacter pylori infection.
    Egan BJ; Marzio L; O'Connor H; O'Morain C
    Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H. pylori treatment: new wine in old bottles?
    Vakil N
    Am J Gastroenterol; 2009 Jan; 104(1):26-30. PubMed ID: 19098845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
    Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
    Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
    Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Tong JL; Ran ZH; Shen J; Xiao SD
    J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
    Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M
    Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.
    Van der Poorten D; Katelaris PH
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1537-42. PubMed ID: 17903237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.